BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McGregor R, Shan L, Wu MF, Siegel JM. Diurnal fluctuation in the number of hypocretin/orexin and histamine producing: Implication for understanding and treating neuronal loss. PLoS One 2017;12:e0178573. [PMID: 28570646 DOI: 10.1371/journal.pone.0178573] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Zhou P, Homberg JR, Fang Q, Wang J, Li W, Meng X, Shen J, Luan Y, Liao P, Swaab DF, Shan L, Liu C. Histamine-4 receptor antagonist JNJ7777120 inhibits pro-inflammatory microglia and prevents the progression of Parkinson-like pathology and behaviour in a rat model. Brain Behav Immun 2019;76:61-73. [PMID: 30408497 DOI: 10.1016/j.bbi.2018.11.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
2 Hwang YT, Piguet O, Hodges JR, Grunstein R, Burrell JR. Sleep and orexin: A new paradigm for understanding behavioural-variant frontotemporal dementia? Sleep Medicine Reviews 2020;54:101361. [DOI: 10.1016/j.smrv.2020.101361] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Heiss JE, Yamanaka A, Kilduff TS. Parallel Arousal Pathways in the Lateral Hypothalamus. eNeuro 2018;5:ENEURO. [PMID: 30225361 DOI: 10.1523/ENEURO.0228-18.2018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Orlowska-Feuer P, Smyk MK, Palus-Chramiec K, Dyl K, Lewandowski MH. Orexin A as a modulator of dorsal lateral geniculate neuronal activity: a comprehensive electrophysiological study on adult rats. Sci Rep 2019;9:16729. [PMID: 31723155 DOI: 10.1038/s41598-019-53012-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
5 Tsuneki H, Wada T, Sasaoka T. Chronopathophysiological implications of orexin in sleep disturbances and lifestyle-related disorders. Pharmacology & Therapeutics 2018;186:25-44. [DOI: 10.1016/j.pharmthera.2017.12.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
6 Xiang X, Chen Y, Li K, Fang J, Bickler PE, Guan Z, Zhou W. Neuroanatomical Basis for the Orexinergic Modulation of Anesthesia Arousal and Pain Control. Front Cell Neurosci 2022;16:891631. [DOI: 10.3389/fncel.2022.891631] [Reference Citation Analysis]
7 Azeez IA, Del Gallo F, Cristino L, Bentivoglio M. Daily Fluctuation of Orexin Neuron Activity and Wiring: The Challenge of "Chronoconnectivity". Front Pharmacol 2018;9:1061. [PMID: 30319410 DOI: 10.3389/fphar.2018.01061] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
8 Yilmaz A, Kalsbeek A, Buijs RM. Early changes of immunoreactivity to orexin in hypothalamus and to RFamide peptides in brainstem during the development of hypertension. Neurosci Lett 2021;762:136144. [PMID: 34332031 DOI: 10.1016/j.neulet.2021.136144] [Reference Citation Analysis]
9 Berteotti C, Lo Martire V, Alvente S, Bastianini S, Bombardi C, Matteoli G, Ohtsu H, Lin JS, Silvani A, Zoccoli G. Orexin/Hypocretin and Histamine Cross-Talk on Hypothalamic Neuron Counts in Mice. Front Neurosci 2021;15:660518. [PMID: 34093114 DOI: 10.3389/fnins.2021.660518] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Thannickal TC, John J, Shan L, Swaab DF, Wu MF, Ramanathan L, McGregor R, Chew KT, Cornford M, Yamanaka A, Inutsuka A, Fronczek R, Lammers GJ, Worley PF, Siegel JM. Opiates increase the number of hypocretin-producing cells in human and mouse brain and reverse cataplexy in a mouse model of narcolepsy. Sci Transl Med 2018;10:eaao4953. [PMID: 29950444 DOI: 10.1126/scitranslmed.aao4953] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 12.3] [Reference Citation Analysis]
11 Mehr JB, Bilotti MM, James MH. Orexin (hypocretin) and addiction. Trends Neurosci 2021;44:852-5. [PMID: 34642086 DOI: 10.1016/j.tins.2021.09.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 McGregor R, Thannickal TC, Siegel JM. Pleasure, addiction, and hypocretin (orexin). Handb Clin Neurol 2021;180:359-74. [PMID: 34225941 DOI: 10.1016/B978-0-12-820107-7.00022-7] [Reference Citation Analysis]
13 Yu X, Franks NP, Wisden W. Brain Clocks, Sleep, and Mood. Adv Exp Med Biol 2021;1344:71-86. [PMID: 34773227 DOI: 10.1007/978-3-030-81147-1_5] [Reference Citation Analysis]
14 Fragale JE, James MH, Aston-Jones G. Intermittent self-administration of fentanyl induces a multifaceted addiction state associated with persistent changes in the orexin system. Addict Biol 2021;26:e12946. [PMID: 32798290 DOI: 10.1111/adb.12946] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
15 James MH, Stopper CM, Zimmer BA, Koll NE, Bowrey HE, Aston-Jones G. Increased Number and Activity of a Lateral Subpopulation of Hypothalamic Orexin/Hypocretin Neurons Underlies the Expression of an Addicted State in Rats. Biol Psychiatry 2019;85:925-35. [PMID: 30219208 DOI: 10.1016/j.biopsych.2018.07.022] [Cited by in Crossref: 47] [Cited by in F6Publishing: 56] [Article Influence: 11.8] [Reference Citation Analysis]
16 González JA, Prehn JH. Orexin-A/hypocretin-1 Immunoreactivity in the Lateral Hypothalamus is Reduced in Genetically Obese but not in Diet-induced Obese Mice. Neuroscience 2018;369:183-91. [DOI: 10.1016/j.neuroscience.2017.11.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
17 Yu X, Franks NP, Wisden W. Sleep and Sedative States Induced by Targeting the Histamine and Noradrenergic Systems. Front Neural Circuits 2018;12:4. [PMID: 29434539 DOI: 10.3389/fncir.2018.00004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 6.8] [Reference Citation Analysis]
18 Scammell TE, Jackson AC, Franks NP, Wisden W, Dauvilliers Y. Histamine: neural circuits and new medications. Sleep 2019;42. [PMID: 30239935 DOI: 10.1093/sleep/zsy183] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
19 Ahmadi-Soleimani SM, Azizi H, Abbasi-Mazar A. Intermittent REM sleep deprivation attenuates the development of morphine tolerance and dependence in male rats. Neurosci Lett 2021;748:135735. [PMID: 33592307 DOI: 10.1016/j.neulet.2021.135735] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Sabetghadam A, Grabowiecka-nowak A, Kania A, Gugula A, Blasiak E, Blasiak T, Ma S, Gundlach AL, Blasiak A. Melanin-concentrating hormone and orexin systems in rat nucleus incertus: Dual innervation, bidirectional effects on neuron activity, and differential influences on arousal and feeding. Neuropharmacology 2018;139:238-56. [DOI: 10.1016/j.neuropharm.2018.07.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
21 Zegarra‐valdivia JA, Pignatelli J, Fernandez de Sevilla ME, Fernandez AM, Munive V, Martinez‐rachadell L, Nuñez A, Torres Aleman I. Insulin‐like growth factor I modulates sleep through hypothalamic orexin neurons. FASEB j 2020;34:15975-90. [DOI: 10.1096/fj.202001281rr] [Cited by in Crossref: 6] [Article Influence: 3.0] [Reference Citation Analysis]
22 Kaushik MK, Aritake K, Cherasse Y, Imanishi A, Kanbayashi T, Urade Y, Yanagisawa M. Induction of narcolepsy-like symptoms by orexin receptor antagonists in mice. Sleep 2021:zsab043. [PMID: 33609365 DOI: 10.1093/sleep/zsab043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]